Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS)

Schizophrenia Research - Tập 128 - Trang 91-97 - 2011
A. James1,2, M. Hough3, S. James1, L. Winmill1, L. Burge1, S. Nijhawan1, P.M. Matthews3,4, M. Zarei3,4
1Highfield Adolescent Unit, Warneford Hospital, Oxford, United Kingdom
2Oxford University Department of Psychiatry, Warneford Hospital, Oxford, United Kingdom
3FMRIB Centre, Department of Clinical Neurology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
4GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital and Department of Clinical Neurosciences, Imperial College, London, United Kingdom

Tài liệu tham khảo

Andreasen, 1977, The family history method using diagnostic criteria. Reliability and validity, Arch. Gen. Psychiatry, 34, 1229, 10.1001/archpsyc.1977.01770220111013 Andreasen, 1999, Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms, Biol. Psychiatry, 46, 908, 10.1016/S0006-3223(99)00152-3 Andreasson, 1987, Cannabis and schizophrenia. A longitudinal study of Swedish conscripts, Lancet, 2, 1483, 10.1016/S0140-6736(87)92620-1 American Psychiatric Association - APA (1994). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC. Arevalo-Martin, 2007, Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2, Eur. J. Neurosci., 26, 1548, 10.1111/j.1460-9568.2007.05782.x Arnone, 2008, Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics, Neuroimage, 41, 1067, 10.1016/j.neuroimage.2008.02.064 Arseneault, 2002, Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study, BMJ, 325, 1212, 10.1136/bmj.325.7374.1212 Basavarajappa, 2009, Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration, Mini Rev. Med. Chem., 9, 448, 10.2174/138955709787847921 Bhattacharyya, 2009, Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis, Arch. Gen. Psychiatry, 66, 442, 10.1001/archgenpsychiatry.2009.17 Bossong, 2010, Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia, Prog. Neurobiol., 92, 370, 10.1016/j.pneurobio.2010.06.010 Bossong, 2009, Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum, Neuropsychopharmacology, 34, 759, 10.1038/npp.2008.138 Coulston, 2007, The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use, Schizophr. Res., 96, 169, 10.1016/j.schres.2007.08.006 Dekker, 2011, Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia, Psychiatry Res., 181, 51, 10.1016/j.pscychresns.2009.06.003 DeLisi, 2008, The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?, Curr. Opin. Psychiatry, 21, 140, 10.1097/YCO.0b013e3282f51266 Douaud, 2007, Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia, Brain, 130, 2375, 10.1093/brain/awm184 Douaud, 2009, Schizophrenia delays and alters maturation of the brain in adolescence, Brain, 132, 2437, 10.1093/brain/awp126 Fergusson, 2003, Cannabis dependence and psychotic symptoms in young people, Psychol. Med., 33, 15, 10.1017/S0033291702006402 Fernandez-Espejo, 2009, Role of cannabis and endocannabinoids in the genesis of schizophrenia, Psychopharmacology (Berl.), 206, 531, 10.1007/s00213-009-1612-6 Fride, 2008, Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development, J. Neuroendocrinol., 20, 75, 10.1111/j.1365-2826.2008.01670.x Genovese, 2002, Thresholding of statistical maps in functional neuroimaging using the false discovery rate, Neuroimage, 15, 870, 10.1006/nimg.2001.1037 Giedd, 2008, The teen brain: insights from neuroimaging, J. Adolesc. Health, 42, 335, 10.1016/j.jadohealth.2008.01.007 Gogtay, 2008, Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia, Schizophr. Bull., 34, 30, 10.1093/schbul/sbm103 Gomez, 2007, The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain, Brain Res., 1145, 48, 10.1016/j.brainres.2007.01.102 Goncalves, 2008, A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner, Mol. Cell. Neurosci., 38, 526, 10.1016/j.mcn.2008.05.001 Good, 2001, A voxel-based morphometric study of ageing in 465 normal adult human brains, Neuroimage, 14, 21, 10.1006/nimg.2001.0786 Grant, 2003, Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study, J. Int. Neuropsychol. Soc., 9, 679, 10.1017/S1355617703950016 Gruber, 2005, Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation, Brain Res. Cogn. Brain Res., 23, 107, 10.1016/j.cogbrainres.2005.02.016 Henquet, 2005, Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people, BMJ, 330, 11, 10.1136/bmj.38267.664086.63 Henquet, 2005, The environment and schizophrenia: the role of cannabis use, Schizophr. Bull., 31, 608, 10.1093/schbul/sbi027 Hollis, 2008, Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD), Schizophr. Res., 105, 216, 10.1016/j.schres.2008.07.010 Jacobus, 2009, White matter integrity in adolescents with histories of marijuana use and binge drinking, Neurotoxicol. Teratol., 31, 349, 10.1016/j.ntt.2009.07.006 Jager, 2007, Effects of frequent cannabis use on hippocampal activity during an associative memory task, Eur. Neuropsychopharmacol., 17, 289, 10.1016/j.euroneuro.2006.10.003 James, 2004, Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescent-onset schizophrenia, Am. J. Psychiatry, 161, 1023, 10.1176/appi.ajp.161.6.1023 Jockers-Scherubl, 2007, Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls, Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 1054, 10.1016/j.pnpbp.2007.03.006 Kaufman, 1997, Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data, J. Am. Acad. Child Adolesc. Psychiatry, 36, 980, 10.1097/00004583-199707000-00021 Kay, 1989, The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation, Br. J. Psychiatry Suppl., 59, 10.1192/S0007125000291514 Konings, 2008, Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad, Acta Psychiatr. Scand., 118, 209, 10.1111/j.1600-0447.2008.01202.x Kuepper, 2010, Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines, Schizophr. Res., 121, 107, 10.1016/j.schres.2010.05.031 Kumra, 2005, Correlates of substance abuse in adolescents with treatment-refractory schizophrenia and schizoaffective disorder, Schizophr. Res., 73, 369, 10.1016/j.schres.2004.08.006 Leweke, 1999, Elevated endogenous cannabinoids in schizophrenia, NeuroReport, 10, 1665, 10.1097/00001756-199906030-00008 Macleod, 2007, Cannabis use and symptom experience amongst people with mental illness: a commentary on Degenhardt et al, Psychol. Med., 37, 913, 10.1017/S0033291707000359 Malone, 2010, Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models, Br. J. Pharmacol., 160, 511, 10.1111/j.1476-5381.2010.00721.x Matochik, 2005, Altered brain tissue composition in heavy marijuana users, Drug Alcohol Depend., 77, 23, 10.1016/j.drugalcdep.2004.06.011 Mauri, 2006, Substance abuse in first-episode schizophrenic patients: a retrospective study, Clin. Pract. Epidemiol. Ment. Health, 2, 4, 10.1186/1745-0179-2-4 Moore, 2007, Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review, Lancet, 370, 319, 10.1016/S0140-6736(07)61162-3 Murray, 2008, Schizophrenia: from developmental deviance to dopamine dysregulation, Eur. Neuropsychopharmacol., 18, S129, 10.1016/j.euroneuro.2008.04.002 Nichols, 2002, Nonparametric permutation tests for functional neuroimaging: a primer with examples, Hum. Brain Mapp., 15, 1, 10.1002/hbm.1058 Oldfield, 1971, The assessment and analysis of handedness: the Edinburgh inventory, Neuropsychologia, 9, 97, 10.1016/0028-3932(71)90067-4 Patenaude, B., 2007, Bayesian Statistical Models of Shape and Appearance for Subcortical Brain Segmentation, Department of Neurology D.Phil. Thesis. University of Oxford. Peters, 2009, Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity?, Psychopharmacol. Bull., 42, 75 Peters, 2010, Diffusion tensor imaging in the early phase of schizophrenia: what have we learned?, J. Psychiatr. Res., 44, 993, 10.1016/j.jpsychires.2010.05.003 Pistis, 2004, Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons, Biol. Psychiatry, 56, 86, 10.1016/j.biopsych.2004.05.006 Pope, 2003, Early-onset cannabis use and cognitive deficits: what is the nature of the association?, Drug Alcohol Depend., 69, 303, 10.1016/S0376-8716(02)00334-4 Rais, 2008, Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients, Am. J. Psychiatry, 165, 490, 10.1176/appi.ajp.2007.07071110 Rodriguez de Fonseca, 1993, Presence of cannabinoid binding sites in the brain from early postnatal ages, NeuroReport, 4, 135, 10.1097/00001756-199302000-00005 Rodriguez-Sanchez, 2010, Cannabis use and cognitive functioning in first-episode schizophrenia patients, Schizophr. Res. Schneider, 2008, Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure, Addict. Biol., 13, 253, 10.1111/j.1369-1600.2008.00110.x Semple, 2005, Cannabis as a risk factor for psychosis: systematic review, J. Psychopharmacol., 19, 187, 10.1177/0269881105049040 Smith, 2009, Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference, Neuroimage, 44, 83, 10.1016/j.neuroimage.2008.03.061 Smith, 2004, Advances in functional and structural MR image analysis and implementation as FSL, Neuroimage, 23, S208, 10.1016/j.neuroimage.2004.07.051 Smith, 2006, Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data, Neuroimage, 31, 1487, 10.1016/j.neuroimage.2006.02.024 Sporn, 2003, Progressive brain volume loss during adolescence in childhood-onset schizophrenia, Am. J. Psychiatry, 160, 2181, 10.1176/appi.ajp.160.12.2181 Stefanis, 2004, Early adolescent cannabis exposure and positive and negative dimensions of psychosis, Addiction, 99, 1333, 10.1111/j.1360-0443.2004.00806.x Szeszko, 2007, Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia, Br. J. Psychiatry, 190, 230, 10.1192/bjp.bp.106.024521 Tamnes, 2010, Intellectual abilities and white matter microstructure in development: A diffusion tensor imaging study, Hum. Brain Mapp., 10.1002/hbm.20962 Thompson, 2005, Structural MRI and brain development, Int. Rev. Neurobiol., 67, 285, 10.1016/S0074-7742(05)67009-2 Tzavara, 2006, Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications, Biol. Psychiatry, 59, 508, 10.1016/j.biopsych.2005.08.019 Tzilos, 2005, Lack of hippocampal volume change in long-term heavy cannabis users, Am. J. Addict., 14, 64, 10.1080/10550490590899862 van Os, 2002, Cannabis use and psychosis: a longitudinal population-based study, Am. J. Epidemiol., 156, 319, 10.1093/aje/kwf043 van Os, 2008, Gene–environment interactions in schizophrenia: review of epidemiological findings and future directions, Schizophr. Bull., 34, 1066, 10.1093/schbul/sbn117 Veen, 2004, Cannabis use and age at onset of schizophrenia, Am. J. Psychiatry, 161, 501, 10.1176/appi.ajp.161.3.501 Veling, 2008, Cannabis use and genetic predisposition for schizophrenia: a case-control study, Psychol. Med., 38, 1251, 10.1017/S0033291708003474 Wechsler, 1999 Wenger, 2002, The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats, Life Sci., 70, 1407, 10.1016/S0024-3205(01)01516-8 Whalley, 2004, fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia, Brain, 127, 478, 10.1093/brain/awh070 White, 2006, Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects, Biol. Psychiatry, 60, 463, 10.1016/j.biopsych.2006.01.002 Yucel, 2008, Regional brain abnormalities associated with long-term heavy cannabis use, Arch. Gen. Psychiatry, 65, 694, 10.1001/archpsyc.65.6.694 Yucel, 2010, The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample, Schizophr Bull. Yucel, 2010, White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study, J. Psychiatry Neurosci., 35, 409, 10.1503/jpn.090177 Zammit, 2004, A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses, Arch. Gen. Psychiatry, 61, 354, 10.1001/archpsyc.61.4.354